Medroxyprogesterone acetate impairs human dendritic cell activation and function

STUDY QUESTION: Does medroxyprogesterone acetate (MPA) impair human dendritic cell (DC) activation and function? SUMMARY ANSWER: In vitro MPA treatment suppressed expression of CD40 and CD80 by human primary DCs responding to Toll-like receptor 3 (TLR3) agonist stimulation (i.e. DC activation). More...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hum Reprod
Main Authors: Quispe Calla, N.E., Ghonime, M.G., Cherpes, T.L., Vicetti Miguel, R.D.
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2015
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4481667/
https://ncbi.nlm.nih.gov/pubmed/25740884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/humrep/dev035
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares